Litcius/Paper detail

Immune mechanisms of group B coxsackievirus induced viral myocarditis

Yue Zhang, Xiaobin Zhou, Shuyi Chen, Xinchen Sun, Chenglin Zhou

2023Virulence41 citationsDOIOpen Access PDF

Abstract

Viral myocarditis is known to be a primary cause of dilated cardiomyopathy (DCM) that can lead to heart failure and sudden cardiac death and is invariably caused by myocardial viral infection following active inflammatory destruction of the myocardium. Although acute viral myocarditis frequently recovers on its own, current chronic myocarditis therapies are unsatisfactory, where the persistence of viral or immunological insults to the heart may play a role. Cellular and mouse experimental models that utilized the most prevalent Coxsackievirus group B type 3 (CVB3) virus infection causing myocarditis have illustrated the pathophysiology of viral myocarditis. In this review, immunological insights into the different stages of development of viral myocarditis were discussed, concentrating on the mechanisms of innate and adaptive immunity in the development of CVB3-induced myocarditis.

Topics & Concepts

MyocarditisViral MyocarditisCoxsackievirusDilated cardiomyopathyImmunologyVirusAcquired immune systemBiologyImmune systemCardiomyopathyInflammationVirologyHeart failureEnterovirusMedicineInternal medicineViral Infections and Immunology Researchinterferon and immune responsesNF-κB Signaling Pathways
Immune mechanisms of group B coxsackievirus induced viral myocarditis | Litcius